phosphorus sesquisulfide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID Source	ID
PubMed CID	14818
MeSH ID	M0104561

Synonyms (26)

Synonym
phosphorus sesquisulfide, free from yellow or white phosphorous
sesquisulfure de phosphore
phosphorus sesquisulfide, free from yellow or white phosphorous [un1341] [flammable solid]
unii-8v5q0m194y
8v5q0m194y ,
hsdb 1257
trisulfurated phosphorus
sesquisulfure de phosphore [french]
phosphorus sulfide (p4s3)
3,5,7-trithia-1,2,4,6-tetraphosphatricyclo(2.2.1.02,6)heptane
phosphorous sesquisulfide
phosphorus (iii) sulfide (iv)
einecs 215-245-0
phosphorus(iii) sulfide(iv)
ai3-15014
un1341
phosphorus sesquisulfide
tetraphosphorus trisulfide
1314-85-8
3,5,7-trithia-1,2,4,6-tetraphosphatricyclo[2.2.1.02,6]heptane
un-1341
tetraphosphorus trisulfide [mi]
phosphorus sesquisulfide [hsdb]
DTXSID4074562
p4s3
Q2454591

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (14)

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	8 (57.14)	18.7374
1990's	2 (14.29)	18.2507
2000's	3 (21.43)	29.6817
2010's	1 (7.14)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 33.52

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

Metric	This Compound (vs All)
Research Demand Index	33.52 (24.57)
Research Supply Index	2.77 (2.92)
Research Growth Index	4.27 (4.65)
Search Engine Demand Index	42.51 (26.88)
Search Engine Supply Index	2.07 (0.95)

This Compound (33.52)

All Compounds (24.57)

Study Types

Publication Type	This drug (%)	All Drugs (%)
Trials	1 (7.14%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	8 (57.14%)	4.05%
Observational	0 (0.00%)	0.25%
Other	5 (35.71%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Classes	Roles
chlorine chloride : A halide anion formed when chlorine picks up an electron to form an an anion.	2.03	1	halide anion; monoatomic chlorine	cofactor; Escherichia coli metabolite; human metabolite
nickel Nickel: A trace element with the atomic symbol Ni, atomic number 28, and atomic weight 58.69. It is a cofactor of the enzyme UREASE.. nickel ion : A nickel atom having a net electric charge.. nickel atom : Chemical element (nickel group element atom) with atomic number 28.	7.05	1	metal allergen; nickel group element atom	epitope; micronutrient
iodine [no description available]	2.03	1	halide anion; monoatomic iodine	human metabolite
phosphorus Phosphorus: A non-metal element that has the atomic symbol P, atomic number 15, and atomic weight 31. It is an essential element that takes part in a broad variety of biochemical reactions.	8.56	9	monoatomic phosphorus; nonmetal atom; pnictogen	macronutrient

Condition	Relationship Strength	Studies	Trials
Chronic Illness [description not available]	2.05	1	0
Recrudescence [description not available]	2.39	2	0
Allergic Contact Dermatitis [description not available]	9.32	4	1
External Ear Inflammation [description not available]	2.05	1	0
Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2).	2.05	1	0
Otitis Externa Inflammation of the OUTER EAR including the external EAR CANAL, cartilages of the auricle (EAR CARTILAGE), and the TYMPANIC MEMBRANE.	7.05	1	0
Dermatitis, Allergic Contact A contact dermatitis due to allergic sensitization to various substances. These substances subsequently produce inflammatory reactions in the skin of those who have acquired hypersensitivity to them as a result of prior exposure.	4.32	4	1
Acute Disease Disease having a short and relatively severe course.	2.06	1	0
Dermatitis, Eczematous [description not available]	2.34	2	0
Hormone-Dependent Neoplasms [description not available]	1.92	1	0
Eczema A pruritic papulovesicular dermatitis occurring as a reaction to many endogenous and exogenous agents (Dorland, 27th ed).	7.34	2	0
Adverse Drug Event [description not available]	1.92	1	0
Contact Dermatitis [description not available]	3.05	5	0
Dermatitis Any inflammation of the skin.	1.92	1	0
Dermatitis, Contact A type of acute or chronic skin reaction in which sensitivity is manifested by reactivity to materials or substances coming in contact with the skin. It may involve allergic or non-allergic mechanisms.	3.05	5	0
Drug-Related Side Effects and Adverse Reactions Disorders that result from the intended use of PHARMACEUTICAL PREPARATIONS. Included in this heading are a broad variety of chemically-induced adverse conditions due to toxicity, DRUG INTERACTIONS, and metabolic effects of pharmaceuticals.	1.92	1	0
Jaw Diseases Diseases involving the JAW.	2.03	1	0
Aseptic Necrosis of Bone [description not available]	2.03	1	0
Osteonecrosis Death of a bone or part of a bone, either atraumatic or posttraumatic.	2.03	1	0
Hives [description not available]	2.65	3	0
Urticaria A vascular reaction of the skin characterized by erythema and wheal formation due to localized increase of vascular permeability. The causative mechanism may be allergy, infection, or stress.	2.65	3	0
Eczema, Atopic [description not available]	1.96	1	0
Facial Dermatoses Skin diseases involving the FACE.	2.37	2	0
Dermatitis, Atopic A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.	1.96	1	0
Leg Dermatoses A nonspecific term used to denote any cutaneous lesion or group of lesions, or eruptions of any type on the leg. (From Stedman, 25th ed)	1.96	1	0
Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed)	3.38	1	1

chemdatabank.com